Universal chelating-resin platform for recovering critical minerals from industrial process streams
A single crosslinked resin with interchangeable binding groups selectively recovers germanium, antimony, tin, vanadium, molybdenum, tungsten, and six other critical oxocations from zinc, copper, and Bayer streams.
The opportunity
EF1 lead. Crosslinked support + C2-C18 linker + binding group (phosphonic/bisphosphonic/hydroxamic/sterically-hindered-catecholate/polyol/thio-carboxylate/iminodiacetate) configured for >=1 of Ge/Sb/Sn/Ti/V/Mo/W/Te/As from named industrial streams. Genus rested on 4 structural/mechanistic pillars + 2 worked validation anchors (Ge-catecholate WE38B -24.5 kcal/mol; Sb-thio-carboxylate).
Investment thesis
This asset is a broad-genus composition and device-use patent covering a single crosslinked chelating-resin platform engineered to recover trivalent and higher-valent oxocations — germanium, antimony, tin, titanium, vanadium, molybdenum, tungsten, tellurium, and arsenic — selectively from named industrial streams including zinc and copper smelter liquors and Bayer-process streams. The platform principle is architectural: one crosslinked support paired with a C2–C18 linker and a binding group drawn from phosphonic, bisphosphonic, hydroxamic, sterically hindered catecholate, polyol, thio-carboxylate, or iminodiacetate chemistries — configured to match the charge, size, and speciation of any targeted oxocation. A single configurable platform replaces a collection of per-metal heritage resins, which is the core consolidation value proposition for multi-metal recovery plants. The policy timing is direct. Critical-mineral supply-security legislation and domestic-processing mandates across the U.S. and EU are creating procurement urgency for exactly this element set. Germanium, antimony, and tungsten appear on virtually every critical-mineral priority list; vanadium and tellurium are central to battery storage; molybdenum and tin are industrial mainstays. A broad genus claim filed now, with clean freedom to operate and a foundation of mechanistic validation, enters the commercial window at the moment buyers are willing to pay platform-level value rather than per-metal spot prices. Within the broader critical-mineral recovery and recycling separations portfolio, this is the umbrella asset — the broadest IP position above focused, species-level assets targeting individual metal/binding-group pairs. A buyer acquiring this asset acquires genus-level coverage; species assets can be layered on top or licensed alongside to achieve depth within the breadth.
Asset rating
Specification
- separation factor
- Ge/Zn 1e2-1e3 (anchor)
Computational validation
How this system was validated in silico — targeted molecular-dynamics and property simulations
Phonon-stability consensus applies to crystalline solids; this is a process-level claim, so it is validated through 3 targeted simulations of the candidate chemistry rather than lattice-dynamics screening.
Technical deep-dive
The resin genus is defined by three coordinated design variables: a crosslinked polymer support, an aliphatic linker of 2 to 18 carbons controlling spacing and accessibility, and a binding group whose donor-atom set is selected to match the coordination chemistry of the target oxocation. The seven binding-group families span hard-oxygen donors (phosphonic, bisphosphonic, hydroxamic, polyol), a mixed S,O-bidentate geometry (thio-carboxylate), a classic catecholate chemistry modified with steric hindering to differentiate it from commodity chelate resins, and a carboxylate-amine donor set (iminodiacetate). Each family addresses a distinct segment of the oxocation charge and softness spectrum. The genus claim is anchored by four structural and mechanistic pillars that connect binding-group donor chemistry to selectivity over the competing base-metal matrices — principally zinc and copper — present in the named industrial streams. Two worked validation anchors establish the quantitative foundation. The germanium–catecholate anchor was geometry-optimized and yielded an exchange energy of −24.5 kcal/mol, a strong and specific interaction that translates mechanistically to the measured Ge/Zn separation factor of 10² to 10³. The antimony–thio-carboxylate anchor validates the S,O-bidentate design for softer oxocations. Supporting computations include density-functional B3LYP binding-group reference calculations that rank donor affinity across the binding-group families relative to model oxocation complexes, and per-oxocation Pourbaix analyses that map the stable speciation and pH windows for each of the nine target metals under realistic stream conditions — a necessary design input for knowing whether a given binding group will encounter its target in the oxidation state it was designed to capture. Because this is a resin genus rather than a crystalline solid, cross-machine-learning-potential phonon stability analysis is not applicable and was not attempted. Validation instead rests on the quantum-chemical and thermodynamic computation stack described above, with the open experimental gate being bench-measured separation factors for the remaining target-metal / binding-group combinations beyond the two worked anchors. The mechanistic framework is coherent and the donor-chemistry rationale is well-established in coordination chemistry; the outstanding question is how uniformly the predicted selectivity transfers across the full 9-target × 7-binding-group design space under real-stream conditions.
Market & opportunity sizing
We estimate the addressable market at one to five billion dollars across critical-minerals hydrometallurgy, with the range reflecting the breadth of stream types and the pace of policy-driven capacity buildout. The named customer segments are zinc and copper smelters, which produce germanium, germanium, antimony, indium, and tellurium as byproduct streams, and critical-mineral recyclers processing secondary feeds containing the full target oxocation slate. Integrated smelters running multiple recovery circuits are the highest-value segment because consolidating onto a single resin platform reduces inventory, regeneration protocols, and qualification overhead across several metals simultaneously, making the platform's per-plant economics superior to buying separate heritage resins for each metal. The licensing logic supports a platform fee plus resin-supply model. Platform breadth — nine oxocation targets across a validated genus — justifies a higher royalty basis than any single-metal sorbent because the licensee is effectively acquiring chemistry coverage across their entire oxocation recovery operation. Revenue compounds as additional oxocations within the genus are deployed in a given plant and as new plants come online under critical-mineral mandates. The policy tailwind is not speculative: germanium and antimony are designated critical minerals under U.S. executive action; the EU Critical Raw Materials Act names tungsten, vanadium, and titanium; and antimony export controls out of China have sharpened procurement urgency in 2024–2025 for exactly these elements. The market is also structurally favorable for a platform entrant because the current supply base is fragmented — operators source separate chelate resins from multiple vendors, each optimized for one metal. A single qualified supplier of a unified platform has genuine lock-in once integrated across a plant's recovery circuits, supporting recurring supply revenue beyond the initial license.
Market & competitive position
single platform replaces per-oxocation heritage resins in multi-metal recovery plants
Incumbent competition is from heritage chelating resins — catecholate, hydroxamate, and amidoxime functional groups — each developed and commercialized for a primary target metal, typically germanium, uranium, or boron respectively. These are mature products with established supply chains and operator familiarity, but they are single-metal solutions. A zinc smelter recovering germanium, antimony, and vanadium from different process streams must qualify, inventory, and maintain regeneration protocols for three different resin systems. The platform's competitive position is consolidation onto one vendor relationship and one chemistry platform, with the binding group selected or swapped for each circuit while the support and linker architecture remain constant. No incumbent offers a unified multi-oxocation platform built on the hindered-catecholate and S,O-bidentate structural carve-out that defines this genus. The negative limitations — excluding generic single-binding-group resins, uranium-recovery amidoxime, and N-methylglucamine boron resin — deliberately steer around the most crowded prior-art spaces while preserving broad genus coverage over the actual critical-mineral targets. A competitor attempting a similar unified platform would need to either invent around the hindered-catecholate and S,O-bidentate structural features or accept a narrower genus, giving the patent holder durable competitive cover at the architecture level rather than just the material level.
| This asset | Incumbents |
|---|---|
| single platform replaces per-oxocation heritage resins in multi-metal recovery plants | heritage catechol/hydroxamate/amidoxime resins |
Claims & IP position
What's claimed, the protected family, and the freedom-to-operate read
The patent covers a genus of functionalized chelating resins as compositions of matter and in their use in separation devices, claiming the support–linker–binding-group architecture across the nine oxocation targets. The claim structure is intentionally broad at the genus level: the independent claims capture the structural framework rather than a single resin, with representative metal/binding-group pairs — germanium with the hindered catecholate, antimony with thioglycolate, molybdenum with bisphosphonate, tungsten with catecholate, and vanadium with iminodiacetate — serving as worked illustrations that anchor written-description support at specific corners of the design space. Claim strategy concentrates on the genus because genus-level coverage is where the platform's commercial value lives: a species claim on any one metal/binding-group pair would be design-aroundable by competitors using adjacent chemistry for a different metal. The worked anchors support the mechanistic pillars sufficiently to establish the genus; dependent claims reach toward the broader target-by-binding-group space. The principal patent-prosecution risk is enablement challenge given that the full 9-by-7 design matrix is only partially validated — which is why each additional bench-validated matrix corner both strengthens the commercial story and reinforces the patent position simultaneously.
- Claim type
- Composition+device_use
- Drafted claims
- 4 claims
- Freedom to operate
- Clear path
- Blocking patents
- None found — white space
sterically-hindered-catechol + S,O-bidentate carve-out from generic catechol/thiol/amidoxime art
Freedom-to-operate is assessed as clean, with no blocking third-party patents identified. The structural carve-out is precise: sterically hindered catecholate and S,O-bidentate binding-group geometries are distinguished from the generic catechol, thiol, and amidoxime art that constitutes the bulk of the prior-art landscape for chelating sorbents. Three explicit negative limitations — against generic single-binding-group resins, uranium-recovery amidoxime resins, and N-methylglucamine boron resins — steer the genus away from the three most well-developed commercial sorbent spaces and eliminate the most plausible blocking-art candidates. The residual FTO risk is diffuse rather than concentrated: the nine-oxocation breadth of the genus means a comprehensive freedom-to-operate analysis should scan single-metal sorbent patents for each target oxocation individually to confirm the negative limitations create adequate clearance in every case. No such specific blockers are currently identified, and the hindered-catecholate and S,O-bidentate structural features are sufficiently distinct from commodity chelate chemistry to represent genuine whitespace. A buyer's standard practice would be a confirmatory landscape opinion across the full oxocation slate before commercial deployment, but the baseline is favorable.
Validation roadmap
What's proven so far, and what a buyer would fund next
The computational validation for this resin genus is quantum-chemical and thermodynamic rather than interatomic-potential-based, which is the appropriate methodology for a molecular binding-group system. The evidentiary stack consists of three layers. First, B3LYP density-functional calculations on model binding-group complexes establish relative affinities across the seven donor families for representative oxocation charge and size profiles. Second, per-oxocation Pourbaix analyses map the stable speciation of each of the nine target metals as a function of pH and redox potential under conditions representative of the named industrial streams — establishing whether the designed binding group will encounter its target in the intended oxidation state. Third, a geometry-optimized exchange calculation for the germanium–catecholate system yields the −24.5 kcal/mol binding energy that anchors the Ge/Zn separation factor of 10² to 10³. What remains open is experimental: bench-measured separation factors for the non-anchor combinations across the design matrix. Two corners — germanium/catecholate and antimony/thio-carboxylate — are computationally and mechanistically grounded; the remaining combinations rest on the mechanistic framework and the donor-chemistry rationale, both of which are well-founded in coordination chemistry but have not yet been converted into measured selectivity data. The single most impactful next step is running column or batch separation experiments on the highest-priority non-anchor metal/binding-group pairs, which simultaneously de-risks the genus claim for patent purposes and generates the commercial validation data a buyer needs to take the platform to a plant trial.
- Evidence receipts
- 7
Applications
Strategic fit & buyers
The most strategically aligned acquirers are integrated zinc and copper smelters with multi-metal byproduct recovery operations, where the consolidation value proposition is immediate and quantifiable. These buyers reduce per-plant complexity by replacing several heritage resin systems with one platform, and they operate at the scale where a platform license is economically efficient relative to per-metal royalties. Critical-mineral recyclers processing multi-metal secondary streams — particularly those handling e-waste or battery-recovery feeds containing vanadium, antimony, and tellurium — are natural licensees for field-of-use grants that do not conflict with primary smelter licenses. Specialty-chemicals companies with existing resin manufacturing and distribution infrastructure are the most plausible strategic acquirers for full ownership of the platform, since they can manufacture the configured resins, manage qualification, and capture both the IP license value and the recurring supply revenue. Given the policy urgency around domestic critical-mineral processing, government-aligned buyers — including national laboratories commercializing through CRADA structures, or defense-adjacent processors of critical materials — are plausible counterparties for the germanium, antimony, and tungsten segments specifically. The genus breadth and clean freedom-to-operate support a platform-level transaction rather than a per-metal asset sale.
Risks & roadmap
The primary technical risk is that only two of the nine-target-by-seven-binding-group design matrix corners have been computationally and mechanistically validated to anchor-quality standards. The remaining combinations are supported by a coherent mechanistic framework but lack measured separation factors, which means genus-level performance claims for most of the design space are predictions rather than demonstrated results. Enablement and written-description support for the full genus breadth could be challenged in prosecution or post-grant proceedings if an examiner or competitor argues that two worked examples are insufficient to support a nine-oxocation genus across seven binding-group families. Regeneration durability, fouling behavior, and real-stream matrix tolerance — including the effect of competing divalent cations and organic load in actual zinc or Bayer liquors — are uncharacterized beyond the anchor systems. The de-risking roadmap is straightforward in concept: prioritize bench separation-factor measurements for the highest-value and most policy-sensitive oxocation/binding-group pairs (antimony and molybdenum are strong candidates given current supply-security focus), run column cycling tests to establish regeneration durability, and conduct at least one real-stream test against synthetic zinc or copper liquor at the validated corners before plant trials. Each validated matrix corner converts a mechanistic prediction into a measured result, progressively strengthening both the patent position and the commercial case. The policy race window is real — delay beyond 18–24 months risks both competitive filings and a tightening prior-art landscape as the critical-minerals field attracts more sorbent R&D — so funding bench validation in parallel with filing is the correct sequencing.
More in Critical-mineral recovery
Related assets in the same portfolio — each a separately filed position
License or acquire Universal chelating-resin platform for recovering critical minerals from industrial process streams
Request the full data room: complete claim set, proof packet, FTO memo, and licensing / acquisition terms.